Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01472354 · ClinicalTrials.gov registry record · NA

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults

A NA study of Hepatitis C, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01472354 is a NA study of Hepatitis C that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 50 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01472354, a NA study of Hepatitis C, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of the LEAP-C (learning, experiencing and preparing for hepatitis C treatment) study is to see if a brief (4-week) small group intervention will help people with HIV/HCV co-infection make an informed decision about Hepatitis C treatment.

Conditions Studied

Hepatitis C

Interventions

  • BEHAVIORAL Leap-c group intervention

Study Locations (1)

Massachusetts

  • University of Massachusetts Graduate School of Nursing - Worcester

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2010-10
Est. Completion 2012-11
Phase NA

Sponsor

University of Massachusetts, Worcester

240 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01472354

The ClinicalTrials.gov registry entry for NCT01472354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (97% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Leap-c group intervention is the first listed.

NCT01472354 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01472354 about?

NCT01472354 is a clinical study titled "Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults". The purpose of the LEAP-C (learning, experiencing and preparing for hepatitis C treatment) study is to see if a brief (4-week) small group intervention will help people with HIV/HCV co-infection make an informed decision about Hepatitis C treatment.

What is the current status of trial NCT01472354?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-10. Estimated completion is 2012-11.

What conditions does trial NCT01472354 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT01472354?

The interventions under investigation include: Leap-c group intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01472354?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01472354 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.